Domov › Rakovina pľúc › New York › Queens
Klinické štúdie Rakovina pľúc v meste Queens, NY
22 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v meste Queens a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 míľ odtiaľ
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Prebieha náborFáza 3
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Queens Hospital Center, Jamaica · 2 míľ odtiaľ
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Prebieha náborFáza 3
- Optum Medical Care, PC, Westbury · 14 míľ odtiaľ
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Prebieha náborFáza 2
- MSK Nassau, Uniondale · 13 míľ odtiaľ
A Registry for People With Lung Cancer
Prebieha náborObservačná štúdia
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Prebieha náborFáza 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Prebieha náborFáza 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 míľ odtiaľ
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 míľ odtiaľ
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Clinical Research Alliance, Westbury · 14 míľ odtiaľ
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Prebieha náborFáza 1
- NYU Langone Health - Long Island, Mineola · 11 míľ odtiaľ
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Prebieha náborFáza 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9 míľ odtiaľ
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 míľ odtiaľ
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Prebieha náborFáza 3
- NYU Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
A Study of Lung Cancer Risk
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 míľ odtiaľ
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Prebieha nábor
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 míľ odtiaľ
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- Clinical Research Alliance, Westbury · 14 míľ odtiaľ
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 míľ odtiaľ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Prebieha náborObservačná štúdia
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 míľ odtiaľ
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Hempstead · 12 míľ odtiaľ
Štúdie Rakovina pľúc v iných mestách
- Houston, TX78 štúdií
- Boston, MA62 štúdií
- New York City, NY60 štúdií
- Los Angeles, CA45 štúdií
- Arlington, VA41 štúdií
- Washington, DC41 štúdií
- Chicago, IL41 štúdií
- Baltimore, MD40 štúdií
- Nashville, TN40 štúdií
- St. Louis, MO39 štúdií
- Columbus, OH37 štúdií
- Philadelphia, PA36 štúdií
Iné štúdie v Queens
- Rakovina prsníka64 štúdií
- Nemalobunkový karcinóm pľúc49 štúdií
- Kolorektálny karcinóm31 štúdií
- Metastatická rakovina28 štúdií
- Rakovina vaječníkov28 štúdií
- Rakovina prostaty27 štúdií
- Rakovina (všetky typy)26 štúdií
- Rakovina endometria25 štúdií
- Akútna myeloidná leukémia21 štúdií
- Mnohonásobný myelóm20 štúdií
- Rakovina pankreasu20 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku20 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.